VSee Health Co-CEO Among Keynote Speakers at iA-MED 2024: Future of Artificial Intelligence
VSee Health (Nasdaq: VSEE) announced that co-CEO Milton Chen, PhD, will be a keynote speaker at iA-Med 2024, a symposium focused on AI advancements in healthcare. The event, presented by ProntoMedic, will take place on October 16, 2024, in San Salvador. It aims to promote innovation and collaboration among healthcare professionals in the AI era.
Other keynote speakers include Jesús Seáñez, PhD, co-founder of Hera Diagnostics, and Alejandro Castillo, a technology business leader. The symposium will cover topics such as predictive diagnostics, personalized treatments, and AI-driven healthcare solutions. The agenda includes sessions on healthcare trends, AI applications, and a panel discussion on ethical implications of AI in healthcare.
VSee Health (Nasdaq: VSEE) ha annunciato che il co-CEO Milton Chen, PhD, sarà uno dei relatori principali all'iA-Med 2024, un simposio incentrato sui progressi dell'IA nella sanità. L'evento, presentato da ProntoMedic, si svolgerà il 16 ottobre 2024, a San Salvador. L'obiettivo è promuovere l'innovazione e la collaborazione tra i professionisti della salute nell'era dell'IA.
Altri relatori principali includono Jesús Seáñez, PhD, co-fondatore di Hera Diagnostics, e Alejandro Castillo, un leader nel settore tecnologico. Il simposio affronterà temi come diagnostica predittiva, trattamenti personalizzati e soluzioni sanitarie guidate dall'IA. L'agenda include sessioni sulle tendenze della salute, le applicazioni dell'IA e una tavola rotonda sulle implicazioni etiche dell'IA nella sanità.
VSee Health (Nasdaq: VSEE) anunció que el co-CEO Milton Chen, PhD, será un ponente principal en iA-Med 2024, un simposio centrado en los avances de la IA en la atención médica. El evento, presentado por ProntoMedic, tendrá lugar el 16 de octubre de 2024, en San Salvador. Su objetivo es promover la innovación y colaboración entre los profesionales de la salud en la era de la IA.
Otros ponentes principales incluirán a Jesús Seáñez, PhD, cofundador de Hera Diagnostics, y Alejandro Castillo, un líder empresarial en tecnología. El simposio cubrirá temas como diagnósticos predictivos, tratamientos personalizados y soluciones de atención médica impulsadas por IA. La agenda incluye sesiones sobre tendencias en salud, aplicaciones de IA y una discusión en panel sobre las implicaciones éticas de la IA en la atención médica.
VSee Health (Nasdaq: VSEE)는 공동 CEO인 밀턴 첸(PhD)이 헬스케어에서의 AI 발전에 초점을 맞춘 iA-Med 2024의 기조 연설자가 될 것이라고 발표했습니다. 이 행사는 ProntoMedic이 주최하며 2024년 10월 16일 산살바도르에서 열립니다. 이 행사는 AI 시대의 의료 전문가들 간의 혁신과 협업을 촉진하는 것을 목표로 합니다.
기타 기조 연설자로는 헤라 진단의 공동 창립자인 헤수스 세아네즈(PhD)와 기술 비즈니스 리더인 알레한드로 카스티요가 포함됩니다. 이 심포지엄은 예측 진단, 맞춤형 치료 및 AI 기반 헬스케어 솔루션과 같은 주제를 다룰 것입니다. agenda에는 의료 동향, AI 애플리케이션 및 의료 분야에서 AI의 윤리적 함의에 대한 패널 토의 세션이 포함됩니다.
VSee Health (Nasdaq: VSEE) a annoncé que le co-CEO Milton Chen, PhD, sera l'un des intervenants principaux lors de iA-Med 2024, un symposium axé sur les avancées de l'IA dans le secteur de la santé. L'événement, présenté par ProntoMedic, se déroulera le 16 octobre 2024, à San Salvador. Son objectif est de promouvoir l'innovation et la collaboration entre les professionnels de la santé à l'ère de l'IA.
Parmi les autres intervenants principaux figurent Jesús Seáñez, PhD, cofondateur de Hera Diagnostics, et Alejandro Castillo, un leader dans le secteur technologique. Le symposium abordera des sujets tels que diagnostics prédictifs, traitements personnalisés et solutions de santé pilotées par l'IA. L'agenda comprend des sessions sur les tendances en matière de santé, les applications de l'IA et une discussion en panel sur les implications éthiques de l'IA dans le domaine de la santé.
VSee Health (Nasdaq: VSEE) gab bekannt, dass Co-CEO Milton Chen, PhD, als Hauptredner beim iA-Med 2024 auftreten wird, einem Symposium, das sich auf Fortschritte der KI im Gesundheitswesen konzentriert. Die von ProntoMedic präsentierte Veranstaltung findet am 16. Oktober 2024 in San Salvador statt. Ziel ist es, Innovation und Zusammenarbeit unter Gesundheitsfachleuten im KI-Zeitalter zu fördern.
Weitere Hauptredner sind Jesús Seáñez, PhD, Mitgründer von Hera Diagnostics, und Alejandro Castillo, ein führender Geschäftsleiter im Technologiesektor. Das Symposium behandelt Themen wie prädiktive Diagnostik, personalisierte Behandlungen und KI-gesteuerte Gesundheitslösungen. Die Agenda umfasst Sitzungen über Gesundheitstrends, KI-Anwendungen und eine Podiumsdiskussion über die ethischen Implikationen von KI im Gesundheitswesen.
- VSee Health's co-CEO Milton Chen is a keynote speaker at a prominent AI in healthcare symposium, potentially enhancing the company's visibility and thought leadership in the field
- The event sponsorship by VSee Health may increase brand awareness and networking opportunities in the healthcare AI sector
- None.
Symposium for healthcare professionals assembles international experts to discuss digital health and AI applications to transform the practice of healthcare
(Graphic: Business Wire)
Presented by ProntoMedic, an early-stage incubator, the event will take place at Auditorio FEPADE in
iA-MED 2024 is sponsored by Banco Agrícola, Applaudo Studios and VSee Health, and aims to promote innovation, collaboration and decision-making by healthcare professionals in the age of AI. Held under the theme of integrating AI into modern healthcare, the symposium will address key topics including predictive diagnostics, personalized treatments and the future of AI-driven healthcare solutions.
Event Highlights:
Keynote Speakers
- Milton Chen, PhD, founder of VSee Health. Dr. Chen is a leading voice in telemedicine technology, impacting underserved communities globally through humanitarian efforts and high-profile collaborations with organizations including NASA and McKesson.
- Jesús Seáñez, PhD, co-founder of Hera Diagnostics, a pioneer in using optoelectronics and AI for early cancer detection. With over a decade of experience, Dr. Seáñez’s innovative devices, such as InstaPAP® and HeraFem®, are revolutionizing cancer diagnostics.
-
Alejandro Castillo, technology business leader and entrepreneur with over 20 years of experience working with Fortune 100 companies and tech startups. Mr. Castillo is MIT-Certified AI for Business and holds a postgraduate degree in AI from the University of
Texas ,Austin .
Agenda
- The Present and Future of Healthcare: An introduction to healthcare trends, future predictions and the growing role of AI.
- Introduction to AI: An overview of machine learning, deep learning and generative AI with a specific focus on healthcare applications.
- AI in Healthcare: A session on the impact of AI on diagnostics, treatment plans and patient outcomes, covering real-world examples as well as critical issues like data privacy and cybersecurity.
- Expert Panel Discussion: A lively discussion on the ethical and practical implications of AI in healthcare, followed by an audience Q&A session.
- Generative AI Applications in Healthcare**: A look at how generative AI is transforming the healthcare discovery process.
Date: October 16, 2024
Time: 3:00 p.m. - 6:00 p.m.
Location: Auditorio FEPADE,
For more information and to purchase tickets, please scan the QR code or contact: social.media@prontotecsa.com
About ProntoMedic
ProntoMedic is an early-stage incubator of innovative digital healthcare solutions, strategically positioned at the crossroads of Latin American and global healthcare systems. With operational hubs in
About VSee Health
VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.
With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, and tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009397315/en/
Investor Contact:
LHA Investor Relations
Tirth T. Patel
212-201-6614
tpatel@lhai.com
Media Contact:
VSee Health
Anne Chang
Media Coordinator
626-513-1824
media@vsee.com
Source: VSee Health, Inc.
FAQ
When and where is the iA-MED 2024 symposium featuring VSee Health's co-CEO taking place?
What is the main focus of the iA-MED 2024 symposium where VSee Health (VSEE) is participating?
Who are the keynote speakers at the iA-MED 2024 event alongside VSee Health's (VSEE) co-CEO?
What topics will be covered in the agenda of the iA-MED 2024 symposium featuring VSee Health (VSEE)?
